This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDRX1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,585.03, is for the delivery of CELLCEPT 250 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 27, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, and the company maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/27/25, 9:50 AM